diabetes mellitus, type 2

Showing 1 - 25 of 2,916

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Blood Metabolic Markers in Type 2 Diabetes Mellitus of Different

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • No intervention
  • Jinan, Shandong, China
    Peng Wu
Nov 24, 2023

Glucose Metabolism Disorders, Diabetes, Type 2, Hypoglycemic Agents Trial in Karachi (Empagliflozin 10 MG,

Recruiting
  • Glucose Metabolism Disorders
  • +3 more
  • Empagliflozin 10 MG
  • Insulin+Metformin+DPP4 inhibitor (DPP4I)
  • Karachi, Pakistan
    SINA Shireen Jinnah colony
Nov 28, 2023

Saudi Arabia to Understand How Dose Check App Used With Tresiba

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Al Khobar, Saudi Arabia
  • +6 more
Nov 23, 2023

Diabetes, Type 2, Overweight or Obesity Trial (HIIT snacks, Sprint snacks, Control)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Overweight or Obesity
  • HIIT snacks
  • +2 more
  • (no location specified)
Nov 22, 2023

Diabetes, Type 2 Trial in Changchun (AP026 (TQA2226) for injection, AP026 (TQA2226) for injection matching )

Recruiting
  • Diabetes Mellitus, Type 2
  • AP026 (TQA2226) for injection
  • AP026 (TQA2226) for injection matching placebo
  • Changchun, Jilin, China
    The first hospital of Jilin University
Nov 16, 2023

Diabetes, Type 2, Overweight and Obesity, Non-Alcoholic Fatty Liver Disease Trial (Dietary macronutrient composition)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • +3 more
  • Dietary macronutrient composition
  • (no location specified)
Nov 16, 2023

Diabetes, Type 2 Trial (NW Low-Glu®, Metformin)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • (no location specified)
Nov 20, 2023

Diabetes, Type 2 Trial in Seoul (administration of UI068, administration of UIC202205, UIC202206)

Completed
  • Diabetes Mellitus, Type 2
  • administration of UI068
  • administration of UIC202205, UIC202206
  • Seoul, Gwanak-gu, Korea, Republic of
    H plus Yangji Hospital
Nov 15, 2023

Diabetes, Type 2 Trial in Cruz-Quebrada (HIIT)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • HIIT
  • Cruz-Quebrada, Oeiras, Portugal
    Faculdade de Motricidade Humana
Nov 15, 2023

Diabetes, Type 2 Trial (Telemonitoring 1, Telemonitoring 2)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Telemonitoring 1
  • Telemonitoring 2
  • (no location specified)
Nov 14, 2023

Obesity, Liver Diseases, Liver Fibrosis Trial in Boston (ESG, GLP1-RA)

Not yet recruiting
  • Obesity
  • +16 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Nov 14, 2023

Periodontitis, Diabetes, Type 2 Trial in Istanbul (Non-Surgical Periodontal Treatment)

Completed
  • Periodontitis
  • Diabetes Mellitus, Type 2
  • Non-Surgical Periodontal Treatment
  • Istanbul, Turkey
    Marmara University
Nov 11, 2023

Diabetes, Type 2 Trial in Italy (Health promotion, Usual care)

Recruiting
  • Diabetes Mellitus, Type 2
  • Health promotion
  • Usual care
  • Catanzaro, Italy
  • +3 more
Nov 9, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza Garcia, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Diabetes, Type 2, Obesity, Prediabetic State Trial in Toronto (Early (7:00 - 16:00) TRE, Mid (9:30 - 18:30) TRE, Late (12:00 -

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • +3 more
  • Early (7:00 - 16:00) TRE
  • +2 more
  • Toronto, Ontario, Canada
    Remote Ontario-wide
Oct 31, 2023

Glucagon-like Peptide-1 Receptor Agonists According to Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Bari, Italy
    Azienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023

Obesity, Diabetes, Type 2 Trial in Copenhagen (Large liquid meal, spinal catheter and venous line)

Recruiting
  • Obesity
  • Diabetes Mellitus, Type 2
  • Large liquid meal, spinal catheter and venous line
  • Copenhagen, Denmark
    Deparrtment of clinical pharmacology
Oct 30, 2023

Diabetes, Type 2, Diabetes Type 2 in Obese Trial in Washington (low-fat vegan diet)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Diabetes Mellitus Type 2 in Obese
  • low-fat vegan diet
  • Washington, District of Columbia
    Physicians Committee for Responsible Medicine
Oct 31, 2023

Italy to Understand How Dose Check App Used With Xultophy®

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Catanzaro, Cz, Italy
  • +1 more
Oct 27, 2023

Metabolic Syndrome, Complementary Therapies, Diabetes, Type 2 Trial (Fenobet, Placebo)

Not yet recruiting
  • Metabolic Syndrome
  • +2 more
  • Fenobet
  • Placebo
  • (no location specified)
Nov 1, 2023

Diabetes, Type 2, PreDiabetes, Metabolic Syndrome Trial (The Cleerly CAD Staging System)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • The Cleerly CAD Staging System
  • (no location specified)
Oct 31, 2023

Endothelial Function and Regenerative Cell Exhaustion

Not yet recruiting
  • Diabetes Mellitus, Type 2
    • Scarborough, Ontario, Canada
      Diagnostic Assessment Centre
    Oct 25, 2023